APA (7th ed.) Citation

Nair, P. M., Starkey, M. R., Haw, T. J., Liu, G., Collison, A. M., Mattes, J., . . . Hansbro, P. M. (2019). Enhancing tristetraprolin activity reduces the severity of cigarette smoke‐induced experimental chronic obstructive pulmonary disease. Clinical & Translational Immunology, 8(10), N.PAG. https://doi.org/10.1002/cti2.1084

Chicago Style (17th ed.) Citation

Nair, Prema M., et al. "Enhancing Tristetraprolin Activity Reduces the Severity of Cigarette Smoke‐induced Experimental Chronic Obstructive Pulmonary Disease." Clinical & Translational Immunology 8, no. 10 (2019): N.PAG. https://doi.org/10.1002/cti2.1084.

MLA (9th ed.) Citation

Nair, Prema M., et al. "Enhancing Tristetraprolin Activity Reduces the Severity of Cigarette Smoke‐induced Experimental Chronic Obstructive Pulmonary Disease." Clinical & Translational Immunology, vol. 8, no. 10, 2019, p. N.PAG, https://doi.org/10.1002/cti2.1084.